Cargando…
Second Cancers in Patients with Neuroendocrine Tumors
BACKGROUND: Second cancers have been reported to occur in 10-20% of patients with neuroendocrine tumors (NETs). However, most published studies used data from a single institution or focused only on specific sites of NETs. In addition, most of these studies included second cancers diagnosed concurre...
Autores principales: | Tsai, Hui-Jen, Wu, Chun-Chieh, Tsai, Chia-Rung, Lin, Sheng-Fung, Chen, Li-Tzong, Chang, Jeffrey. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877400/ https://www.ncbi.nlm.nih.gov/pubmed/24392036 http://dx.doi.org/10.1371/journal.pone.0086414 |
Ejemplares similares
-
The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
por: Tsai, Hui-Jen, et al.
Publicado: (2013) -
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan
por: Chang, Jeffrey S., et al.
Publicado: (2021) -
Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted Therapy: A Nation-Wide Cancer Registry-Based Study From Taiwan
por: Chang, Jeffrey.S., et al.
Publicado: (2015) -
The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998–2008: a nation-wide cancer registry-based study
por: Chiang, Nai-Jung, et al.
Publicado: (2014) -
The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation‐wide cancer registry‐based study from Taiwan
por: Chang, Jeffrey S., et al.
Publicado: (2018)